|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBOOKCENTRAL_ocn909899425 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
150425t20142014dcu o 000 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d CUS
|d OCLCO
|d YDXCP
|d OCLCF
|d OCLCO
|d EBLCP
|d DEBSZ
|d OCLCO
|d OCLCQ
|d OCLCO
|d IDB
|d OCLCQ
|d MERUC
|d OCLCQ
|d VT2
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 922042431
|a 923291273
|a 957737318
|a 958084174
|
| 020 |
|
|
|a 9780309368407
|q (e-book)
|
| 020 |
|
|
|a 0309368405
|q (e-book)
|
| 029 |
1 |
|
|a AU@
|b 000067006614
|
| 029 |
1 |
|
|a DEBBG
|b BV043624581
|
| 029 |
1 |
|
|a DEBSZ
|b 449742482
|
| 035 |
|
|
|a (OCoLC)909899425
|z (OCoLC)922042431
|z (OCoLC)923291273
|z (OCoLC)957737318
|z (OCoLC)958084174
|
| 050 |
|
4 |
|a T174.5
|b .I578 2014eb
|
| 082 |
0 |
4 |
|a 363.1
|2 23
|
| 049 |
|
|
|a UAMI
|
| 110 |
2 |
|
|a Institute of Medicine (U.S.),
|e author.
|
| 245 |
1 |
0 |
|a Characterizing uncertainty in the assessment of benefits and risks of pharmaceutical products :
|b workshop in brief /
|c Institute of Medicine (U.S.).
|
| 264 |
|
1 |
|a [Washington, District of Columbia] :
|b Institute of Medicine of the National Academies,
|c 2014.
|
| 264 |
|
4 |
|c ©2014
|
| 300 |
|
|
|a 1 online resource (8 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Workshop in Brief
|
| 588 |
0 |
|
|a Online resource; title from PDF cover (ebrary, viewed April 25, 2015).
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (NAP, viewed March 26, 2014).
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Risk assessment
|v Congresses.
|
| 650 |
|
0 |
|a Communication
|v Congresses.
|
| 650 |
|
6 |
|a Évaluation du risque
|v Congrès.
|
| 650 |
|
6 |
|a Information
|v Congrès.
|
| 650 |
|
7 |
|a Communication
|2 fast
|
| 650 |
|
7 |
|a Risk assessment
|2 fast
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
| 758 |
|
|
|i has work:
|a Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products (Text)
|1 https://id.oclc.org/worldcat/entity/E39PD3f9XVjhc3JQmctwgMTVfq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Medicine, Institute of.
|t Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : Workshop in Brief.
|d Washington : National Academies Press, ©2015
|
| 830 |
|
0 |
|a Workshop in brief.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379436
|z Texto completo
|
| 936 |
|
|
|a BATCHLOAD
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3379436
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr11042784
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12382306
|
| 994 |
|
|
|a 92
|b IZTAP
|
